Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.

• Sponsor: University of Pittsburgh (Other)
• Overall Status: Completed
• CT.gov ID: NCT00177632
• Collaborator: (none)
• Enrollment: 66
• Location: 1
• Duration (Months): 12
• Patients Per Site Per Month: 5.5

Study Details

Study Description

Brief Summary

The purpose is to examine the additional effect of either yoga or resistance exercise on weight loss weight combined with a standard behavioral weight loss intervention.

Condition or Disease	Intervention/Treatment	Phase
Obesity; Weight Loss	Behavioral: behavioral weight loss	Phase 1/Phase 2

Study Design

• Study Type: Interventional
• Allocation: Randomized
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.
• Study Start Date: Jul 1, 2003
• Study Completion Date: Jul 1, 2004

Outcome Measures

Primary Outcome Measures

1. weight loss []

Secondary Outcome Measures

1. fitness []

2. physical activity []

3. dietary intake []

4. mediators []

Eligibility Criteria

Criteria

• Ages Eligible for Study: 25 Years to 55 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

1. Female

2. 25-55 years of age

3. BMI = 25-35 kg/m2

4. Ability to provide informed consent.

5. Ability to provide consent from their personal physician to participate in this study.

Exclusion Criteria:

1. Participation in regular exercise (aerobic, yoga or resistance exercise) for > 20 minutes per day on > 2 days per week for the last 3 months. (This study is designed to recruit relatively sedentary adults.)

2. Currently being treated for psychological disorders/conditions and/or currently taking psychotropic medication.

3. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism.

4. Women who are currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. However, pregnancy status will also be verified by the pregnancy test that is required for the baseline, 6 and 12 month DEXA).

5. Non-medicated resting systolic blood pressure >160 mmHg or non-medicated resting diastolic blood pressure >100 mmHg, or taking medication that would affect blood pressure.

6. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade).

7. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated.

8. History of myocardial infarction or valvular disease.

9. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Pittsburgh	Pittsburgh	Pennsylvania	United States	15203

Sponsors and Collaborators

• University of Pittsburgh

Investigators

• Principal Investigator: John M Jakicic, Ph.D., University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00177632
• Other Study ID Numbers: 0402119
• First Posted: Sep 15, 2005
• Last Update Posted: Sep 15, 2005
• Last Verified: Sep 1, 2005

• Additional relevant MeSH terms: Body Weight; Overweight; Weight Loss

Study Results

No Results Posted as of Sep 15, 2005